Tamsulosin Hydrochloride Capsule
Product Images NDC 50268-740

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 50268-740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label Tamsulosin 5026874015)

Tamsulosin Hydrochloride Capsules USP 0.4 mg packaging label shows a box containing 50 unit dose capsules (5 x 10). The label includes storage instructions to keep at 25°C with permitted excursions, and cautions to avoid excess moisture and keep out of reach of children. Labeler is AvPAK, manufactured by Alkem Laboratories Ltd. for AvKARE, Inc.*

FDA Label Image

Tamsulosin-figure1 (Tamsulosin Figure1)

A time-concentration curve chart showing plasma concentration (ng/mL) of a drug over 36 hours. The graph compares plasma levels for two conditions: fasted (dashed line) and fed (solid line), illustrating differences in drug absorption and concentration between these states.*

FDA Label Image

Tamsu-fi2a (Tamsulosin Figure2a)

A line graph showing mean change over duration of treatment in weeks. It compares Tamsulosin Hydrochloride 0.8 mg and 0.4 mg dosage groups against a placebo group. The x-axis represents treatment duration in weeks from baseline (B) to 13 weeks and last observation carried forward (LOCF). The y-axis shows mean change values ranging from 0 to -11.*

FDA Label Image

Tamsu-fig2b (Tamsulosin Figure2b)

A line graph showing mean change in a measured variable over treatment duration in weeks for three groups: 0.8 mg, 0.4 mg Tamsulosin Hydrochloride, and placebo. The graph compares the treatment effects over time with mean change on the vertical axis and weeks on the horizontal axis.*

FDA Label Image

Tamsu-fig3a (Tamsulosin Figure3a)

A line graph showing mean change in a variable (mL/sec) over treatment duration in weeks, comparing three groups: 0.8 mg, 0.4 mg Tamsulosin Hydrochloride, and placebo. The x-axis represents time points up to 52 weeks and the end of the study (LOCF). The y-axis shows mean change values from 0 to 3 mL/sec.*

FDA Label Image

Tamsu-fig3b (Tamsulosin Figure3b)

A line graph showing mean change in mL/sec over treatment duration in weeks. It compares three treatments: 0.8 mg, 0.4 mg of Tamsulosin Hydrochloride, and placebo, with data points at multiple weeks, indicating changes in the measured variable over time.*

FDA Label Image

Tamsulosin-structure (Tamsulosin Structure)

Chemical structure diagram of Tamsulosin Hydrochloride, depicting its molecular arrangement including aromatic rings and associated functional groups, alongside the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.